An Efficacy and Safety Study of DFN-02
Phase of Trial: Phase II
Latest Information Update: 13 Oct 2017
At a glance
- Drugs DFN 02 (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Dr Reddys Laboratories
- 09 Oct 2017 Status changed from active, no longer recruiting to completed.
- 11 Sep 2017 According to The International Headache Society media release, results from this trial presented at the 18th Congress of the International Headache Society.
- 07 Sep 2017 According to a Promius Pharma media release, results from this trial will be presented at the 18th Congress of the International Headache Society.